Simple Summary This is a systematic and meta-analysis study that looked at the
hepatocellular carcinoma recurrence rate and its risk factors after liver transplantation. The …

Liver transplantation (LT) is the treatment of choice for liver failure and selected cases of
malignancies. Transplantation activity has increased over the years, and indications for LT …

Simple Summary While hepatocellular carcinoma (HCC) is inextricably linked to underlying
cirrhosis due to chronic viral hepatitis, alcohol consumption, and non-alcoholic fatty liver …

The use of immunosuppressive medications for solid organ transplantation is associated
with cardiovascular, metabolic, and oncologic complications. On the other hand, the …

Simple Summary Liver transplantation is a curative treatment option for a subset of patients
with hepatocellular carcinoma (HCC). However, about twenty percent of patients develop …

Objective: Health care accounts for up to 8-10% of greenhouse emission yearly in the US
and surgical room contributes an estimated 25-30% of hospital waste. Despite the major role …

Life-long immunosuppression has always been considered the key in managing liver graft
protection from recipient rejection. However, it is associated with severe adverse effects that …

Background: The role of tailored immunosuppression (IS) in the development of the humoral
response (HR) to SARS-CoV-2 mRNA-based vaccination in liver transplant (LT) recipients is …

The potential of adoptive cell therapy with regulatory T cells (Tregs) to promote transplant
tolerance is under active exploration. However, the impact of specific transplant settings and …

Immunosuppression non-adherence is a major cause of graft failure after liver
transplantation. The aim of this study was to evaluate practice surrounding conversion from …